These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 3601886)

  • 1. [Use of a portable drug administration system for long-term insulin administration to diabetics].
    Turakulov IaKh; Akbarov ZS; Allamiiarov BU; Akhmedova ND; Antonova TI
    Probl Endokrinol (Mosk); 1987; 33(2):16-9. PubMed ID: 3601886
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Developmental and application of insulin infusion profiles for therapy of type-I diabetics with portable insulin infusion systems.
    Schulz G; Strack T; Beyer J; Krause U; Cordes U; Weber T; Nagel J; Beutelspacher F
    Life Support Syst; 1984; 2(3):189-200. PubMed ID: 6503348
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Nocturnal continuous subcutaneous insulin infusion--a therapeutic possibility in labile type I diabetes under exceptional conditions].
    Bruns W; Steinborn F; Menzel R; Staritz B; Bibergeil H
    Z Gesamte Inn Med; 1990 Mar; 45(6):154-8. PubMed ID: 2197828
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Short-term subcutaneous infusion of insulin using a portable insulin pump in the treatment of diabetes mellitus].
    Krzymień J; Szymerska E; Bak M; Regulski M; Tracz M
    Pol Arch Med Wewn; 1989 Apr; 81(4):214-22. PubMed ID: 2626347
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Insulin needs of insulin-dependent diabetics during biostator control and subcutaneous use of insulin].
    Petkova M; Khristov V; Tsanev A
    Vutr Boles; 1990; 29(1):74-7. PubMed ID: 2204207
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of type I diabetes with portable insulin infusion devices.
    Raskin P
    Diabetes Care; 1982; 5 Suppl 1():48-52. PubMed ID: 6231168
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Insulin portable pump vs. intensified conventional injections in diabetes].
    Gutman RA; Litwak LE; Fagin JA; Plantalech L; Steiner S
    Medicina (B Aires); 1985; 45(3):225-30. PubMed ID: 3915900
    [No Abstract]   [Full Text] [Related]  

  • 8. [Factors affecting stability in the course of insulin-dependent diabetes mellitus].
    Borisova AM; Koev D; Kirilov G
    Vutr Boles; 1989; 28(3):67-72. PubMed ID: 2672596
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Insulin-mediated glucose disposal in type 1 (insulin-dependent) diabetic subjects treated by continuous subcutaneous or intraperitoneal insulin fusion.
    Beylot M; Khalfallah Y; Laville M; Sautot G; Dechaud H; Serusclat P; Berthezene F; Riou JP; Mornex R
    Diabete Metab; 1987; 13(4):450-6. PubMed ID: 3315766
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Treatment of diabetics using portable insulin pumps].
    Vavrinec J; Kopecký A; Zizkovský V; Lebl J; Sturmová M
    Cesk Pediatr; 1985 Dec; 40(12):701-4. PubMed ID: 4085018
    [No Abstract]   [Full Text] [Related]  

  • 11. [Assessment of self monitoring of blood glucose (SMBG) and continuous subcutaneous insulin infusion (CSII) in diabetic pregnant women].
    Murata K; Toyoda N; Ito M; Rii T; Sugiyama Y; Miyamura Y
    Nihon Sanka Fujinka Gakkai Zasshi; 1985 Dec; 37(12):2749-57. PubMed ID: 4086905
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Blood glucose, C-peptide and glucagon levels in patients with a labile course of diabetes mellitus during use of the device "Biostator"].
    Spesivtseva VG; Turova EA; Mamaeva GG; Sotnikova TI
    Probl Endokrinol (Mosk); 1985; 31(5):63-7. PubMed ID: 4070196
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Recommendations for insulin treatment with a portable insulin pump].
    Gutniak M; Johansson BL; Lager I; Lins PE; Nilsson A; Reichard P; Ostman J
    Lakartidningen; 1984 Nov; 81(48):4507-10. PubMed ID: 6521559
    [No Abstract]   [Full Text] [Related]  

  • 14. [Combined use of automatic systems for treating patients with type 1 diabetes mellitus].
    Perelygina AA; Antsiferov MB; Starostina EG
    Probl Endokrinol (Mosk); 1987; 33(5):3-6. PubMed ID: 3422932
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of prolonged (6 months) alpha-glucosidase inhibition on blood glucose control and insulin requirements in patients with insulin-dependent diabetes mellitus.
    Dimitriadis G; Karaiskos C; Raptis S
    Horm Metab Res; 1986 Apr; 18(4):253-5. PubMed ID: 3519413
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Blood-sugar-controlled insulin infusion systems for rapid adjustment of insulin-dependent diabetics (author's transl)].
    Beyer J; Becker G; Schulz G; Gaberle E; Wolf E; Hassinger W; Cordes U
    Dtsch Med Wochenschr; 1981 Dec; 106(49):1644-9. PubMed ID: 7030687
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preprogrammed insulin infusion with a portable pump system.
    Irsigler K; Kritz H; Kaspar L; Brändle J; Koller W; Franetzki M
    Horm Metab Res Suppl; 1979; (8):193-7. PubMed ID: 119699
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [An improvement in insulin efficacy in patients with type-1 diabetes mellitus following treatment using an insulin infusion pump].
    Borisova AM; Koev D; Kirilov G
    Vutr Boles; 1989; 28(1):74-7. PubMed ID: 2662610
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Insulin resistance in multiple tissues in patients with type 1 diabetes mellitus on long-term continuous subcutaneous insulin infusion therapy.
    Donga E; van Dijk M; Hoogma RP; Corssmit EP; Romijn JA
    Diabetes Metab Res Rev; 2013 Jan; 29(1):33-8. PubMed ID: 22936679
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Clinical course of advanced microvascular complications in diabetic patients undergoing long-term treatment with the subcutaneous insulin infusion pump].
    Calle Pascual AL; Charro Salgado AL
    Med Clin (Barc); 1983 Dec; 81(20):904-7. PubMed ID: 6664146
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.